Nebracetam
Experimental Japanese-developed nootropic known only from rat and laboratory studies; not tested in humans.
Pharmacology
Contents
DETAILED OVERVIEW
What is Nebracetam?
Nebracetam (development code WEB 1881 FU) is an experimental compound from the racetam family, studied in Japanese research. It is not a marketed medicine anywhere and is not recognized as a dietary supplement. It is not approved in the United States, and in Australia it is classed as prescription-only.
It directly switches on one of the brain's acetylcholine receptors (acetylcholine is a messenger involved in learning and memory). In rats it increased the production and release of acetylcholine and gave modest protection to nerve cells from damage after disturbed blood supply to the brain. A laboratory experiment on human cells suggests it may act the same way in humans, but no clinical trial has been done in people, so neither its effect nor its safety in humans is known. Based on its mechanism, it could in theory cause nausea, diarrhea and a slow heartbeat; it may need to be avoided in asthma, heart rhythm problems and ulcers. There is no safety data for pregnancy and breastfeeding.
Mechanism
M1 muscarinic agonist + cholinergic
Evidence
Preclinical (rat, in vitro)
Half-life
N/A (no human data)
Legal status
Investigational (not marketed)
There is virtually no meaningful community or anecdotal experience with Nebracetam: it is an obscure, never-commercialized investigational compound that is rarely sourced or documented. The few mentions typically extrapolate from the preclinical literature on its M1 agonism and neuroprotection rather than from real, repeated user reports. Any description of perceived effects should therefore be treated with strong skepticism, and this entry is a reference, not a usage guide.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- M1 muscarinic ACh receptorStrong
- High-affinity choline uptake / ACh releaseModerate
- Neuroprotection (cerebral ischemia)Moderate
Safety
Side effects, stop signs, contraindications
Side effects · 5
- No human safety data exist; the following are theoretical risks inferred from the cholinergic (muscarinic agonist) mechanism, not observed effects
- Nausea, diarrhea or abdominal cramping, typical of muscarinic overstimulation
- Increased salivation, sweating or lacrimation (peripheral cholinergic effects)
- Headache, as with many other racetams
- Theoretical cardiovascular risk: bradycardia or a drop in blood pressure can occur with muscarinic agonism
Contraindications · 6
- Pregnancy and breastfeeding: no safety data, should be avoided
- Not studied for human use: with no clinical data it is not recommended for human consumption and should be treated only as a research reference
- Bradycardia or cardiac conduction disorder: muscarinic agonism may further slow heart rate
- Asthma or COPD: muscarinic activation may trigger bronchoconstriction
- Peptic ulcer or gastrointestinal disease: increased gastric acid and motility are possible
- Concurrent anticholinergic medications: they may mutually blunt each other's effects
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Effects of nebracetam (WEB 1881 FU), a novel nootropic, as a M1-muscarinic agonist
Kitamura Y, Kaneda T, Nomura Y
Evaluation of the neuroprotective action of WEB 1881 FU on hypoglycemia/hypoxia-induced neuronal damage using rat striatal slices
Koizumi S, Kataoka Y, Shigematsu K, Niwa M, Ueki S
Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats
Takeo S, Hayashi H, Miyake K, Takagi K, Tadokoro M, Takagi N, Oshikawa S
FAQ
FAQ
Nebracetam is a Japanese-developed racetam compound with cholinergic effects, it directly activates one of the brain's acetylcholine receptors, so in theory it could support memory and learning. In rat models it boosted acetylcholine production and release, and showed mild nerve-protective effects in certain brain circulation problems. This too is a purely research-stage substance, backed only by animal and lab (in vitro) data, it has not been studied in humans.
Telegram
Have a question about Nebracetam?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.